HeraMed’s telehealth solutions address self-isolation needs
Finfeed
Archived
Mar 25, 2020
HeraMED Limited (ASX: HMD) has received a significant uplift in interest and demand for its proprietary in-home pregnancy monitoring products HeraBEAT and HeraCARE as communities go into self isolation.
